I agree with @Melody432 that 2Q23 EPS is more likely to be around -38c. @saltland is close at -36c, but I would be surprised if Avita can keep total operating expenses lower than in 1Q23, as Saltland's spreadsheet indicates. I don't understand how consensus can be in the -26 to -34c range. Perhaps some of them don't update their data in a timely manner to take into account the rapid increase in sales reps.
Yes, it's possible that the market, based on consensus, could again be disappointed with the actual quarterly outcome, but I believe that the fundamentals will very shortly come into play, and be better understood by the market when 4Q data is released. It would be better for all if Avita would update the market on their EPS outlook, together with their explanation, well before they release their next quarterly report.
- Forums
- ASX - By Stock
- The near term future
I agree with @Melody432 that 2Q23 EPS is more likely to be...
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.73 |
Change
0.100(3.80%) |
Mkt cap ! $164.3M |
Open | High | Low | Value | Volume |
$2.65 | $2.77 | $2.65 | $575.0K | 209.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3815 | $2.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.78 | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3815 | 2.730 |
1 | 7623 | 2.720 |
3 | 3369 | 2.710 |
3 | 5454 | 2.700 |
2 | 7798 | 2.690 |
Price($) | Vol. | No. |
---|---|---|
2.780 | 3000 | 1 |
2.800 | 2737 | 2 |
2.820 | 1063 | 1 |
2.840 | 12000 | 2 |
2.850 | 1052 | 1 |
Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
Last
$2.75 |
  |
Change
0.100 ( 4.42 %) |
|||
Open | High | Low | Volume | ||
$2.70 | $2.77 | $2.70 | 6470 | ||
Last updated 15.58pm 02/05/2024 ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online